Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) traded up 7.4% during mid-day trading on Wednesday . The company traded as high as $160.0390 and last traded at $160.0390. Approximately 5 shares changed hands during trading, a decline of 99% from the average daily volume of 673 shares. The stock had previously closed at $148.9590.
Merck KGaA Stock Performance
The stock has a market cap of $20.31 billion, a price-to-earnings ratio of 23.99 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a fifty day simple moving average of $144.19 and a 200-day simple moving average of $143.16.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
